Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update

I’m Not Putting on that Floral Gown: Enforcement and Resistance of Gender Expectations for Transgender People with Cancer

(2021) Ash B. Alpert et al.   PATIENT EDUCATION AND COUNSELING

Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey

(2021) Sharon McGee et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation

(2021) Sharon McGee et al.   Journal of Bone Oncology

Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment

(2021) Thomas W. P. Friedl et al.   JAMA Oncology

Adjuvant Zoledronate Therapy for Women With Breast Cancer—Effective Treatment or Fool’s Gold?

(2021) Alexandra Desnoyers et al.   JAMA Oncology

Management of Male Breast Cancer: ASCO Guideline

(2020) Michael J. Hassett et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Michael Gnant et al.   LANCET ONCOLOGY

St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment

(2019) Marija Balic et al.   Breast Care

Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†

(2019) F Cardoso et al.   ANNALS OF ONCOLOGY

Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline

(2019) Noam Yarom et al.   JOURNAL OF CLINICAL ONCOLOGY

Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline

(2019) Charles L. Shapiro et al.   JOURNAL OF CLINICAL ONCOLOGY

Bisphosphonate Choice as Adjuvant Therapy for Breast Cancer: Does It Matter?

(2019) Adam Brufsky et al.   JNCI-Journal of the National Cancer Institute

Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307

(2019) Julie R Gralow et al.   JNCI-Journal of the National Cancer Institute

Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial

(2019) Robert Coleman et al.   LANCET ONCOLOGY

Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data

(2018) Ewan Gray et al.   BRITISH JOURNAL OF CANCER

Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline

(2017) Timothy Gilligan et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update

(2017) Catherine Van Poznak et al.   JOURNAL OF CLINICAL ONCOLOGY

American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations

(2017) Jennifer Griggs et al.   JOURNAL OF CLINICAL ONCOLOGY

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline

(2017) Sukhbinder Dhesy-Thind et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

(2015)   LANCET

Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)

(2012) Peyman Hadji et al.   BREAST CANCER RESEARCH AND TREATMENT